Cargando…
The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression
ERα positive breast cancer accounts for 70% of breast malignancies. Compared with ERα negative types, ERα positive breast cancer could be effective controlled by endocrine therapy. However, more than half of the patients will develop endocrine resistance, making it an important clinical issue for br...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605433/ https://www.ncbi.nlm.nih.gov/pubmed/32973333 http://dx.doi.org/10.1038/s41388-020-01464-z |